33 results about "Chronic Active" patented technology

The invention discloses a new traditional Chinese medicine composition for treating chronic hepatitis and a preparation method thereof. The traditional Chinese medicine composition mainly comprises the following Chinese medicinal herbs of dried orange peel, rhizoma cyperi, pericarpium citri reticulatae viride, radix scrophulariae, root of rehmannia, folium isatidis, root of kudzu vine, houttuynia cordata, indigo naturalis, peach kernel, red flower, radix paeoniae alba, Tuckahoe, rhizoma alismatis, oriental wormwood, desmodium, polygonum cuspidatum, root of red-rooted salvia, radix bupleuri, angelica sinensis, herba lycopi, earthworm, goldthread, felwort and root bark of the peony tree. The traditional Chinese medicine composition can be prepared into a common oral preparation according to a conventional traditional Chinese medicine preparation method. The invention can remarkably improve the symptoms of mild acratia, inappetence, abdominal distension, pain over the liver and the like of chronic persisting hepatitis, and can improve the symptoms of asthenia, poor appetite, abdominal distension, semiliquid, pain over the liver, poor complexion, poorer health, manpower reduction, hepatomegaly accompanied with haphalgesia and rap pain, and splenomegaly of the chronic active hepatitis and the symptoms of jaundice, spider angioma, liver palms, acne and the like caused by the chronic hepatitis. The invention can also improve the symptoms of long-term obvious dysfunction of liver, ALT continuous increase or repeated fluctuation, albumin reduction, globulin increase, gamma globulin or IgG increase, time extension of protrombin time, capability of positive reaction in self antibody and rheumatoid factors, capability of circulating immune complex increase, capability of addiments C3 and C4 reduction and the like, and has accurate remarkable clinical treatment effect and rapid effect taking.

The invention discloses a traditional Chinese medicine composition used for curing chronic hepatitis and a preparation method thereof. The traditional Chinese medicine composition is made of raw material medicines with the weight proportion by parts: 40 to 160 parts of Chinese thorowax root, 40 to 160 parts of debark peony root, 40 to 160 parts of angelica, 40 to 160 parts of India madder root, 40 to 160 parts of largehead atractylodes rhizome, 40 to 160 parts of Tuckahoe, 40 to 160 parts of turtle carapace, 40 to 160 parts of massa medicata fermentata hunanensis, 60 to 240 parts of Codonopsis pilosula nannfeldt, 60 to 240 parts of Lalang Grass Rhizome, 24 to 96 parts of immature orange fruit, 20 to 80 parts of green tangerine peel, 12 to 48 parts of villous amomum fruit, 12 to 48 parts of earthworm and 12 to 48 parts of liguorice. The traditional Chinese medicine composition of the invention has the pharmacological efficacies of antagonizing hepatic damage, protecting liver, regulating immune function, reducing aminopherase, improving liver function and on the like, and the clinical efficacy observation experiments prove that the traditional Chinese medicine composition has the exact efficacies to the chronic hepatitis, in particular to chronic active hepatitis, chronic persisting hepatitis and early cirrhosis; and the clinical application is of safety and no toxicity and side effects.

The Chinese medicine for treating hepatocirrhosis, hepatitis and liver cancer is prepared with main material, subsidiary material and supplementary material and may be granule or mixture. The main material is polystictus versicolar extractive and the supplementary material is compound Qiupi cream. The medicine has the functions of strengthening body's resistance and eliminating evil, regulating body's inside environment comprehensively. It has excellent curative effect on chronic active hepatitis, sustained AFP positive, and primary liver cancer in stage I and II.

The invention provides methods for treating demyelinating inflammatory diseases by administering to the subject an effective amount of an agent that provides activated protein C activity, where the dose is effective to reduce the adverse clinical indicia of the disease. In some embodiments, the patient being treating is of the chronic active plaque type.

The invention relates to the medicine filed, in particular to a medicinal purpose of norisoboldine. The medicinal purpose is characterized in that the norisoboldine can be used in the application of preparing drugs for the treatment of autoimmune diseases. The autoimmune diseases are: rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, multiple sclerosis, type-I diabetes, psoriasis, ulcerative colitis, Sjogren syndrome, scleroderma, polymyositis, chronic active hepatitis, mixed connective tissue disease, primary biliary cirrhosis, autoimmune hemolytic anemia and other diseases.

The application relates to the field of biotechnologies, and particularly relates to a composition, an application and a preparation method. The composition contains hericium erinaceus, sophora alopecuroide and a coptis chinensis extract, and can be used for treating or preventing the various diseases caused by helicobacter pylori, wherein the diseases comprise various digestive system diseases, in particular, gastritis (for example, chronic active gastritis and chronic atrophic gastritis), peptic ulcers (for example, gastric ulcer and duodenal ulcer), ulcerative colitis or digestive tract malignancies (for example, gastric cancer) and the like. The raw materials of the composition disclosed by the invention are easily available, the preparation process is simple, the obtained quality is high in quality, the composite cost is controllable, and the composition is suitable for industrialized production.

The present invention relates to a kind of Chinese medicine for treating hepatitis, especially chronic active hepatitis, and cholecystitis and its preparation process. The Chinese medicine is prepared with false Chinese swertia herb, common pecteilis root, lysimachia, rhubarb, astragalus root and other seven kinds of Chinese medicinal materials. It may be prepared into different clinically acceptable preparation forms. Clinical test proves its obvious curative effect on hepatitis and cholecystitis and no toxic side effect.

The Chinese medicine for treating hepatocirrhosis, hepatitis and liver cancer is prepared with main material, subsidiary material and supplementary material and may be granule or mixture. The main material is polystictus versicolar extractive and the supplementary material is compound Qiupi cream. The medicine has the functions of strengthening body's resistance and eliminating evil, regulating body's inside environment comprehensively. It has excellent curative effect on chronic active hepatitis, sustained AFP positive, and primary liver cancer in stage I and II.

The invention discloses a medical composition and the preparation method for clearing away heat, removing dampness through diuresis, soothing liver and strengthening spleen. The active ingredients of the medical composition are extracted from the following medicinal materials: vinegar-baked bupleurum, oldenlandia diffusa, oriental wormwood, ash bark, isatis root, dandelion, oriental waterplantain rhizome, poria cocos, siebold stonecrop, weeping forsythia, largehead atractylodes rhizome, plantain seed, fried gardenia, fried rhizoma anemarrhenae, common cephalanoplos herb and root of herbaceous peony. The active ingredients of the medical composition has the advantages of clearing away heat, removing dampness through diuresis, soothing liver, strengthening spleen and curing chronic active hepatitis.

The invention discloses a preparation method of a Chinese medicinal pill. The preparation method comprises decocting Penthorum chinense in water for 2-3 times for 1-3h each time, mixing decoctions, filtering, concentrating, cooling, adding ethanol to 55-70% for precipitating, stirring, standing, filtering to obtain filtrate and filter residue, cleaning the filter residue with ethanol, mixing the cleaning solutions and filtrate, recovering ethanol, concentrating to obtain an extract with relative density of 1.30-1.35, mixing with starch, drying, pulverizing, adding 65-85% ethanol, granulating, and packaging. The invention has the advantages of low dose, good dissolubility, and convenient administration. The inventive pill can be used to treat hepatitis, such as chronic active hepatitis, hepatitis B, and acute viral hepatitis.

The present invention discloses one kind of compound preparation comprising monopotassium glycyrrhizunate 20-75 weight portions, glycine 1-800 weight portions, L-cysteine hydrochloride 10-28 weight portions, and one or two of sodium chloride 10-30 weight portions, anhydrous sodium sulfite 10-28 weight portions and disodium edetate 1-9 weight portions. The present invention discloses also its preparation process and application in preparing medicine for treating viral hepatitis, chronic unresolved hepatitis, chronic active hepatitis, etc. Compared with available monopotassium glycyrrhizunate orally taken preparation, the compound preparation of the present invention has the advantages of high curative effect, less side effect, fast acting, high bioavailability, etc.

The invention belongs to the field of health-care products, and in particular relates to a ganoderma liver-protection tea and a preparation method thereof. The preparation method of the ganoderma liver-protection tea comprises the steps of: crushing, mixing, stirring, pelletizing and drying ganoderma capense, ganoderma sinense, ganoderma lucidum karst and raw ganoderma lucidum spore powder to obtain pure ganoderma tea particles, and then spraying traditional Chinese medicine extract on the surface of the pure ganoderma tea particles for drying, thus obtaining the ganoderma liver-protection tea. The ganoderma liver-protection tea adds various traditional Chinese medicinal materials for tonifying and nourishing the liver into raw ganoderma, thus having the obvious effect of protecting the liver; when being supplied for patients with different types of hepatopathy for long-term drinking, the ganoderma liver-protection tea can be cooperative with the conventional hepatopathy drugs so as to protect the liver, degrade enzyme, prevent and treat diseases, and has an obvious curative effect especially on chronic hepatitis, chronic active hepatitis earlier-cirrhosis. The ganoderma liver-protection tea has no toxic and side effects, can be conveniently administrated, and is suitable for long-term administration by patients.

The invention is concerned with the Chinese traditional medicine combination for clearing away the heat-evil and expelling superficial evils, consists of capillary artemisia, Scutellaria barbata D.Don, tuckahoe, radix curcumae, herba lycopi, safflower, bupleurum, amber, and paeonia lactiflora pallas, which can treat clearing hepatitis B virus and early liver cirrhosis. The invention is also concerned with the preparation method and preparation of the Chinese traditional medicine combination.

The invention discloses a traditional Chinese medicine composition used for curing chronic hepatitis and a preparation method thereof. The traditional Chinese medicine composition is made of raw material medicines with the weight proportion by parts: 40 to 160 parts of Chinese thorowax root, 40 to 160 parts of debark peony root, 40 to 160 parts of angelica, 40 to 160 parts of India madder root, 40 to 160 parts of largehead atractylodes rhizome, 40 to 160 parts of Tuckahoe, 40 to 160 parts of turtle carapace, 40 to 160 parts of massa medicata fermentata hunanensis, 60 to 240 parts of Codonopsis pilosula nannfeldt, 60 to 240 parts of Lalang Grass Rhizome, 24 to 96 parts of immature orange fruit, 20 to 80 parts of green tangerine peel, 12 to 48 parts of villous amomum fruit, 12 to 48 parts of earthworm and 12 to 48 parts of liguorice. The traditional Chinese medicine composition of the invention has the pharmacological efficacies of antagonizing hepatic damage, protecting liver, regulating immune function, reducing aminopherase, improving liver function and on the like, and the clinical efficacy observation experiments prove that the traditional Chinese medicine composition has the exact efficacies to the chronic hepatitis, in particular to chronic active hepatitis, chronic persisting hepatitis and early cirrhosis; and the clinical application is of safety and no toxicity and side effects.

A Chinese traditional medicine for curing chronic active hepatitis belongs to the Chinese traditional medicine for curing hepatitis. The ingredients of the medicine (with weights) are milkvetch root 30g, root of red salvia 30g, codonopsis pilosula 15g, angelica 15g, white peony root 15g, cornel 15g, nutgrass galingale rhizome 15g, red peony root 15g, rhizome of giant knotweed 15g, turtle shell 25g, liquorice 5g; the auxiliary ingredients include sanxiange 15g, radish seed 20g and areca 10g under the situation of obvious abdominal distension; rhizoma Corydalis 15g and szechwan chinaberry fruit 10g under the situation of hypochondriac pain; virgate wormwood herb 50g under the situation of obvious jaundice; schisandra fruit 10g under the situation of high-content aminopherase. The medicines used in the prescription are all natural herbs and the Chinese traditional medicine is processed with traditional method; the fetching of material is convenient and the prescription and manufacture method are simple; the expense for manufacturing the medicine is low. The composition of the Chinese herbal medicine is simple and the medicines used in the prescription are all natural ones and the fetching and use are convenient; the manufacture method is simple and the effect is excellent; the price is low; in this way, the herbal medicine is especially fit for people living in remote villages far away from counties and towns; the curing expense for patients with the chronic active hepatitis is low which solves the problem that the household income is low and the life is poor and the medical conditions is deficient locally.

The present invention provides a Chinese medicine composite with the functions of supplementing qi, nourishing liver, clearing away heat and removing toxic material. Said Chinese medicine composite contains 9 Chinese medicinal materials of astragalus root, bushy knotweed root, polyporus, bupleurum root, Chinese anpelica root and others. Said Chinese medicine composite can be effectively curing chronic active hepatitis.

The use of the protein UK114, also known as MSP 14, for the preparation of medicaments for the treatment or the prophylaxis of chronic active hepatitis.

The invention relates to a Ganoderma lucidum honey capable of protecting liver. Traditional Chinese medicine raw materials are added into 5-6 times amount of water to produce water extract of the traditional Chinese medicines, precipitates are filtered out from the water extract, the filtered water extract is mixed with honey according to the weight ratio of 1:1.0-1.5, the mixture is concentrated until the concentration of the traditional Chinese medicine is 5-20%, and then the concentrated mixture is fed to bees, bees take the mixture, honey is collected and poisonous impurities are removed from the honey, so that the Ganoderma lucidum honey capable of protecting liver is obtained. The honey containing various kinds of traditional Chinese medicines are decomposed and made under action of biological enzymes of bees, and the test shows that the content of various beneficial components is higher than 5-10 times that of the common honey. Various traditional Chinese medicines capable of tonifying and nourishing liver are added into the honey raw materials, so that the honey has obvious efficacies of protecting liver and obvious therapy effect on chronic hepatitis and chronic active hepatitis early chronic hepatitis. The Ganoderma lucidum honey does not has any toxic and side effects, and is convenient to take and suitable for long-term administration of patients.

Described herein are methods for treating antibody mediated rejection (ABMR), especially chronic active ABMR (cABMR), of transplanted organs using clazakizumab Human kidney transplant recipients with biopsy-proven cABMR, transplant glomerulopathy and who are donor-specific antibody positive showed stabilization of renal function and lowered DSA levels following clazakizumab treatment. The estimated glomerular filtration rate of the patients at six, 12 or even 18 months were stabilized, inflammatory markers of cABMR were reduced or stabilized, and inflammatory blood markers were reduced, since clazakizumab treatment.

The invention discloses a preparation method of a Chinese medicinal pill. The preparation method comprises decocting Penthorum chinense in water for 2-3 times for 1-3h each time, mixing decoctions, filtering, concentrating, cooling, adding ethanol to 55-70% for precipitating, stirring, standing, filtering to obtain filtrate and filter residue, cleaning the filter residue with ethanol, mixing the cleaning solutions and filtrate, recovering ethanol, concentrating to obtain an extract with relative density of 1.30-1.35, mixing with starch, drying, pulverizing, adding 65-85% ethanol, granulating,and packaging. The invention has the advantages of low dose, good dissolubility, and convenient administration. The inventive pill can be used to treat hepatitis, such as chronic active hepatitis, hepatitis B, and acute viral hepatitis.

The invention discloses a traditional Chinese medicine for treating chronic active hepatitis by coriolus versicolor. The traditional Chinese medicine comprises, by weight, 13-17 parts of artemisia desertorum Spreng. var. tongolensis pamp., 13-17 parts of coriolus versicolor, 4-8 parts of hedyotis diffusa, 10-14 parts of fiveleaf akebia fruit, 4-8 parts of rhizoma gastrodiae, 6-10 parts of radix astragali, 1-5 parts of radix rehmanniae, 4-8 parts of Alectoria asiatica Du Rietz, 10-14 parts of dahurian patrinia herb, 6-10 parts of glossy privet fruit, 13-17 parts of tribulus terrestris, 10-14 parts of Clematis huchouensis Tamura and 6-10 parts of Chinese magnoliavine fruit. Through use of the characteristics of the coriolus versicolor and use of the traditional Chinese medicines having effects of clearing liver and cooling blood, nourishing yin and purging fire, and nourishing kidney and liver, the traditional Chinese medicine can fast produce good effects of treating chronic active hepatitis and has no toxic or side effect.

The invention relates to the medicine filed, in particular to a medicinal purpose of norisoboldine. The medicinal purpose is characterized in that the norisoboldine can be used in the application of preparing drugs for the treatment of autoimmune diseases. The autoimmune diseases are: rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, multiple sclerosis, type-I diabetes, psoriasis, ulcerative colitis, Sjogren syndrome, scleroderma, polymyositis, chronic active hepatitis, mixed connective tissue disease, primary biliary cirrhosis, autoimmune hemolytic anemia and other diseases.

The invention discloses a Chinese medicinal herb for treating chronic hepatitis, which comprises the following components in part by weight: 30 to 60 parts of Indian buead, 50 to 70 parts of Chinese magnoliavine fruit, 30 to 60 parts of common leafflower herb, 30 to 60 parts of Mongolian dandelion herb, 40 to 60 parts of hawthorn fruit, 30 to 80 parts of eucommia bark, 30 to 80 parts of scorch-fried three immortals, 20 to 90 parts of virgate wormwood herb, 40 to 60 parts of radix isatidis, 30 to 70 parts of bitter almond kernel and 300 to 500 parts of honey. Based on Chinese medicinal and pharmacologic theory, through years of clinical practices, the Chinese medicinal herb for treating the chronic hepatitis has a formula consisting of Chinese medicinal herbs which are selected from Chinese medical treasury and have the effects of clearing heat and detoxicating, protecting liver and nourishing liver, regulating vital energy and freeing network vessels. The Chinese medicament has exact treatment effects on various kinds of chronic hepatitis and various kinds of chronic active hepatitis.

The invention relates to the field of capsules, and discloses a Ganu capsule which comprises a capsule shell and Ganu particles contained in the capsule shell. The Gusu granules comprise penthorum chinense pursh clear paste, silicon dioxide and talcum powder, and the penthorum chinense pursh clear paste is prepared by the following steps: chopping penthorum chinense pursh with proper weight, adding water, boiling for N times, combining decoction, filtering, filtering and concentrating into clear paste, adding ethanol to obtain mixed liquor, standing for a period of time, filtering to obtain precipitate, washing the precipitate with ethanol for M times, combining washing liquor and filtrate, and drying to obtain the Gusu granules. Recovering ethanol under reduced pressure until no alcohol smell exists, concentrating to obtain clear paste, and performing spray drying to obtain penthorum chinense pursh clear paste; the capsule shell comprises a capsule shell body and a slow-release structure, the slow-release structure is used for containing Ganu granules and installed in the capsule shell body, a floating piece is arranged on the outer side wall of the upper shell body, and a pendant is arranged on the inner bottom wall of the lower shell body. The traditional Chinese medicine composition is used for chronic active hepatitis and hepatitis B.

The invention is concerned with the Chinese traditional medicine combination for clearing away the heat-evil and expelling superficial evils, consists of capillary artemisia, Scutellaria barbata D.Don, tuckahoe, radix curcumae, herba lycopi, safflower, bupleurum, amber, and paeonia lactiflora pallas, which can treat clearing hepatitis B virus and early liver cirrhosis. The invention is also concerned with the preparation method and preparation of the Chinese traditional medicine combination.

The invention relates to the field of capsules, and discloses a Gansu capsule, which comprises a capsule shell and Gansu granules contained in the capsule shell; the Gansu granules include a plaster of root vegetables, silicon dioxide and talcum powder. Get a suitable weight of root vegetables and chop them, add water and boil N times, then combine the decoction and filter, filter and concentrate to clear paste, add ethanol to obtain a mixed solution, leave it for a period of time, filter to obtain a precipitate, after the precipitate is washed with ethanol M times, merge Washing liquid and filtrate, recovering ethanol under reduced pressure until no alcohol smell and concentrating to clear paste, spray drying to obtain Zhagencai clear paste; the capsule shell includes capsule shell and slow-release structure, and the slow-release structure is used to hold Gansu granules, and the slow-release The structure is installed inside the capsule shell, a floating sheet is arranged on the outer side wall of the upper shell, and a sinker is arranged on the inner bottom wall of the lower shell. Liver, for chronic active hepatitis, hepatitis B.

The invention discloses medicine composition for treating chronic active hepatitis and a preparation method of the medicine composition. The medicine composition for treating chronic active hepatitis comprises ingredients as follows: wild parsley, osbeckia crinita, Rubus saxatilis L., Eurya hebeclados Ling, scolopendra, Chinese brake herb, field sowthistle herb, clematis roots, roots of champion pentasacme, Chinese wedelia herb, flabelate maiden-hair herb, roots of spine aralia, Meconopsis horridula Hook. f. et Thoms. var. racemosa (Maxim.) Prain., swertia punicea, all-grass of maidenhair, sida mysorensis, Iris tectorum Maxim., boor's mustard herb, abrus precatorius leaf extracts, Salvia prionitis Hance extracts and wallich eriophyton nano powder. Traditional Chinese medicines are reasonably selected according to clinical experience for elaborate preparation of the medicine composition; the medicine composition has the efficacy of liver soothing, spleen invigorating, detoxification, liver protection, liver calming for yang suppressing, heat clearing, diuresis, kidney tonification for yang strengthening, regulation of middle-warmer energy and qi tonification, can effectively repair injured cells of the liver, promote recovery of a cell regeneration function, has a remarkable treatment effect on chronic active hepatitis, is safe and does not have side effects, and the medicine property is mild.

The invention provides a ganoderma lucidum tea capable of augmenting the kidney and nourishing the liver, and relates to the field of health-preserving and health-care ganoderma lucidum tea products.As Shennong's Classic of Materia Medica and Compendium of Materia Medica record that green ganoderma lucidum can improve eyesight, tonify liver qi and quiet spirits; black ganoderma lucidum can mainlytreat retention of urine, facilitate water pathways, augment kidney qi and unblock nine orifices; and purple ganoderma lucidum can mainly treat deafness, facilitate joints, protect spirits, augment vital essence, strengthen muscles and bones and turn complexion good. Modern researches claim that trametes versicolor acts on liver, spleen and lung channels, is also used for the prevention and treatment of liver cancer besides hepatitis at home, and has good curative effects on chronic active hepatitis. The ganoderma lucidum tea capable of augmenting the kidney and nourishing the liver is prepared by subjecting the four ganoderma lucidum to elaborate preparation, strengthens the efficacy of ganoderma lucidum tea in tonifying and augmenting the liver and kidney, has the efficacy of tonifyingand augmenting kidney qi, warming the kidney, promoting yang, protecting the liver and reliving toxicity, relieving alcohol effects, nourishing the liver and enhancing the immunity of human bodies, and is suitable for auxiliary treatment on symptoms such as frequent micturition and waist and knee asthenia caused by deficiency of liver qi and kidney qi, liver damages caused by staying up late and excessive smoking and drinking, and low immunity.